Retina Health Market Trends

Key Emerging Trends in the Retina Health Market

The escalating incidence of retinal diseases, encompassing conditions like Age-Related Macular Degeneration (AMD), diabetic retinopathy, retinitis pigmentosa, and retinal detachment, stands out as a pivotal driver propelling the growth of the retina health market. Furthermore, the surge in cases of vision impairment and an increasing population afflicted by myopia, particularly during the COVID-19 pandemic, has further fueled the expansion of the market. The widespread adoption of screens and the prevalence of virtual meetings while working from home have contributed to a higher risk of progressive eye disorders, notably AMD, which has seen a notable uptick. A study published by Springer Nature Limited (Germany) in December 2021 revealed that Age-related Macular Degeneration (AMD) is the predominant cause of blindness among older adults, affecting approximately 1 in 12 adults aged 45 to 85 globally, leading to varying degrees of visual impairment.

Additional data from the American Society of Retina Specialists (US) in 2021 highlighted the substantial impact of age-related macular degeneration in the US, affecting 11 million individuals in that year alone, with an anticipated surge to 22 million people by 2050. The same report indicated that diabetic retinopathy impacted around 7.7 million people in the US in 2021, and this number is projected to double to 15.4 million individuals by 2050. Furthermore, data published by the National Organization for Rare Disorders, Inc. (NORD) in 2021 shed light on the prevalence of Retinitis Pigmentosa (RP), affecting approximately 1 in 3,000 to 1 in 4,000 individuals globally. Considering the current worldwide population surpassing 7.74 billion, an estimated 1.94 to 2.58 million people are affected by RP or related disorders, such as Leber Congenital Amaurosis (LCA), Choroideremia, and Cone-rod dystrophy (CORD). These statistics underscore the considerable impact of retinal diseases on a global scale, substantiating their significant contribution to the robust growth of the overall retina health market.

In conclusion, the surge in retinal diseases, coupled with lifestyle and environmental factors, has positioned the retina health market on an upward trajectory. The repercussions of the COVID-19 pandemic, including increased screen time and a surge in myopia cases, have only amplified the need for effective interventions and treatments targeting retinal health. As these conditions continue to affect millions worldwide, the retina health market is poised to witness sustained growth, driven by advancements in treatment options and an escalating demand for solutions addressing the diverse array of retinal disorders.